Semuloparin (a new LMWH) reduced DVT & PE in chemotherapy patients (RCT, NEJM)
www.pulmccm.org
For unclear reasons, people receiving chemotherapy for solid tumors are at particularly increased risk for deep venous thrombosis and pulmonary embolism (DVT/PE).
Semuloparin (a new LMWH) reduced DVT & PE in chemotherapy patients (RCT, NEJM)
Semuloparin (a new LMWH) reduced DVT & PE in…
Semuloparin (a new LMWH) reduced DVT & PE in chemotherapy patients (RCT, NEJM)
For unclear reasons, people receiving chemotherapy for solid tumors are at particularly increased risk for deep venous thrombosis and pulmonary embolism (DVT/PE).